Correlation Between Microsoft and Shenzhen Bioeasy

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft and Shenzhen Bioeasy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Shenzhen Bioeasy into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Shenzhen Bioeasy Biotechnology, you can compare the effects of market volatilities on Microsoft and Shenzhen Bioeasy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Shenzhen Bioeasy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Shenzhen Bioeasy.

Diversification Opportunities for Microsoft and Shenzhen Bioeasy

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Microsoft and Shenzhen is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Shenzhen Bioeasy Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Bioeasy Bio and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Shenzhen Bioeasy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Bioeasy Bio has no effect on the direction of Microsoft i.e., Microsoft and Shenzhen Bioeasy go up and down completely randomly.

Pair Corralation between Microsoft and Shenzhen Bioeasy

Given the investment horizon of 90 days Microsoft is expected to generate 0.31 times more return on investment than Shenzhen Bioeasy. However, Microsoft is 3.21 times less risky than Shenzhen Bioeasy. It trades about 0.08 of its potential returns per unit of risk. Shenzhen Bioeasy Biotechnology is currently generating about -0.01 per unit of risk. If you would invest  31,876  in Microsoft on August 25, 2024 and sell it today you would earn a total of  9,824  from holding Microsoft or generate 30.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy94.83%
ValuesDaily Returns

Microsoft  vs.  Shenzhen Bioeasy Biotechnology

 Performance 
       Timeline  
Microsoft 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Shenzhen Bioeasy Bio 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Bioeasy sustained solid returns over the last few months and may actually be approaching a breakup point.

Microsoft and Shenzhen Bioeasy Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft and Shenzhen Bioeasy

The main advantage of trading using opposite Microsoft and Shenzhen Bioeasy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Shenzhen Bioeasy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will offset losses from the drop in Shenzhen Bioeasy's long position.
The idea behind Microsoft and Shenzhen Bioeasy Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements